NICE UK approves use of anti-CGRP monoimmune Ajovy to prevent migraines, with patients only need to inject themselves once a month or quarter
-
Last Update: 2020-06-21
-
Source: Internet
-
Author: User
Search more information of high quality chemicals, good prices and reliable suppliers, visit
www.echemi.com
The National Institutes of Health and Health (NICE) recommends teva's anti-cecalingene-related peptide (CGRP) monoantigen Ajovy to prevent chronic migraines, which have previously been used with at least three prophylactic therapies and have no responsethe decision means that Ajovy became the first anti-CGRP prophylaxis recommended by NICE, with patients only given once a month or quarter and have the option of self-injection after trainingat least half of migraine sufferers are diagnosed and undertreatedLess than half of migraine sufferers will seek medical attention, and less than 30 percent of migraine sufferers can control their conditionIt usually manifests as moderate to severe headaches, accompanied by nausea or vomiting, sensitivity to noise, light or odorlast year, Teva also received European Commission approval under two major Phase III clinical trials in which patients treated for migraines significantly reduced the number of migraine days per month by at least 50 percent, with disease relief as early as one week after treatmentone in seven adults in the UK (more than 7.2 million people) suffer from migraines, while women are three times more likely to suffer from migraines than men
This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only.
This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of
the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed
description of the concern or complaint, to
service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content
will be removed immediately.
